| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10070437 | Cancer Treatment Reviews | 2018 | 6 Pages |
Abstract
With increasing follow-up, DFS events are increasing defined by contralateral recurrence and non-breast cancer deaths with a trend for fewer distant recurrences. This may explain the limited association between DFS and overall survival with extended adjuvant endocrine therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ibrahim Algorashi, Hadar Goldvaser, Domen Ribnikar, David W. Cescon, Eitan Amir,